IRIDEX CORPORATION (NASDAQ:IRIX) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
Results of Operations and Financial Condition.
IRIDEX CORPORATION (NASDAQ:IRIX) Files An 8-K Results of Operations and Financial Condition
On November 2, 2017, IRIDEX Corporation issued a press release discussing revenues for its third fiscal quarter of 2017, which ended September 30, 2017.The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
|
Item 9.01. |
Financial Statements and Exhibits. |
|
Exhibit No. |
Description |
|
99.1 |
Press Release dated November 2, 2017. |
IRIDEX CORP ExhibitEX-99.1 2 irix-ex991_6.htm EX-99.1 irix-ex991_6.htm Exhibit 99.1 IRIDEX Announces 2017 Third Quarter Financial Results MOUNTAIN VIEW,…To view the full exhibit click here
About IRIDEX CORPORATION (NASDAQ:IRIX)
IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
